Lytix Biopharma ASA Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Lytix Biopharma ASA stock has an average price target of kr 15.00. The average 1-year stock price forecast is 56.58% higher than the current stock price, while the lowest is kr 14.00 (+46.14%) and the highest is kr 16.00 (+67.01%).

Price Target: kr 15.00 (+56.58%)

Analyst Consensus: n/a

Price Target

Chart

Target	Low	Average	Median	High
Price	kr 14.00	kr 15.00	kr 15.00	kr 16.00
Change	+46.14%	+56.58%	+56.58%	+67.01%

Analyst Ratings

There are currently no analyst ratings available for Lytix Biopharma ASA.

Recommendation Trends

Rating	Apr '26	May '26	Jun '26	Aug '26	Sep '26	Nov '26
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	0	0	0	0	0	0

Financial Forecast

Revenue This Year

12.55M

Revenue Next Year

83.85M

from 12.55M

568.13%

from 12.55M

EPS This Year

-1.35

from -0.88

EPS Next Year

-1.36

from -1.35

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	19.31M	11.03M	3.99M	11.13M	-	12.55M
Operating Income	-47.99M	-65.67M	-96.79M	-95.90M	-64.03M	-82.75M
Net Income	-48.08M	-56.07M	-87.90M	-94.27M	-59.98M	-98.00M
EPS	-	-	-	-	-0.88	-1.35
Free Cash Flow	-	-	-	-	-59.85M	-105.00M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NOK.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	25.1M
Avg	12.6M
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	1,236.3%
Avg	568.1%
Low	-100.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.35
Avg	-1.35
Low	-1.35

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-